UroToday.com
@urotoday
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology
ID: 21319494
19-02-2009 17:36:50
118,118K Tweet
28,28K Takipçi
6,6K Takip Edilen
177-Lutetium-PSMA vs Cabazitaxel: a real-world #mCRPC study. Mike Wenzel, BSc joins Neeraj Agarwal, MD, FASCO to discuss a real-world analysis of cabazitaxel vs. Lu-177 PSMA RLT in mCRPC. Findings from ~300 pts show longer PFS with Lu-177 (13 vs. 7 mos) & a trend toward OS benefit. Sequential